Literature DB >> 19747912

Vav1 and PU.1 are recruited to the CD11b promoter in APL-derived promyelocytes: role of Vav1 in modulating PU.1-containing complexes during ATRA-induced differentiation.

Federica Brugnoli1, Elisabetta Lambertini, Nadine Varin-Blank, Roberta Piva, Marco Marchisio, Silvia Grassilli, Sebastiano Miscia, Silvano Capitani, Valeria Bertagnolo.   

Abstract

Vav1 plays an important role in the all-trans retinoic acid (ATRA)-induced completion of the differentiation program of acute promyelocytic leukemia (APL)-derived cells, in which it strengthens the drug effects and is involved in the regulation of maturation-related proteins, such as the CD11b surface antigen. In both myeloid and lymphoid cells, accumulating data attribute to the multidomain protein Vav1 a functional relevance in the control of gene expression, by direct interaction with chromatin remodeling and/or transcriptional proteins. The present study provides evidence that, in the APL-derived NB4 cell line, Vav1 and the transcription factor PU.1 cooperate in regulating the ATRA-induced CD11b expression. Both chromatin immunoprecipitation (ChIP) experiments and electrophoretic mobility shift assays (EMSA) indicate that Vav1 and PU.1 are recruited to CD11b promoter. Even if the two proteins may participate in diverse protein/DNA complexes, the amounts of complexes including PU.1 seem to be dependent on the interaction of this transcription factor with tyrosine-phosphorylated Vav1. The reported data suggest that the ATRA-induced increase of Vav1 expression and tyrosine phosphorylation may be involved in recruiting PU.1 to its consensus sequence on the CD11b promoter and, ultimately, in regulating CD11b expression during the late stages of neutrophil differentiation of APL-derived promyelocytes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19747912     DOI: 10.1016/j.yexcr.2009.09.004

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  19 in total

1.  Vav1 in hematologic neoplasms, a mini review.

Authors:  Matthew J Oberley; Deng-Shun Wang; David T Yang
Journal:  Am J Blood Res       Date:  2012-01-01

2.  A network including PU.1, Vav1 and miR-142-3p sustains ATRA-induced differentiation of acute promyelocytic leukemia cells - a short report.

Authors:  Silvia Grassilli; Ervin Nika; Elisabetta Lambertini; Federica Brugnoli; Roberta Piva; Silvano Capitani; Valeria Bertagnolo
Journal:  Cell Oncol (Dordr)       Date:  2016-08-01       Impact factor: 6.730

3.  TGFβ promotes mesenchymal phenotype of pancreatic cancer cells, in part, through epigenetic activation of VAV1.

Authors:  P-H Huang; P-J Lu; L-Y Ding; P-C Chu; W-Y Hsu; C-S Chen; C-C Tsao; B-H Chen; C-T Lee; Y-S Shan; C-S Chen
Journal:  Oncogene       Date:  2016-11-28       Impact factor: 9.867

4.  PU.1 acts as tumor suppressor for myeloma cells through direct transcriptional repression of IRF4.

Authors:  N Ueno; N Nishimura; S Ueno; S Endo; H Tatetsu; S Hirata; H Hata; M Matsuoka; H Mitsuya; Y Okuno
Journal:  Oncogene       Date:  2017-04-03       Impact factor: 9.867

5.  α-Tocopherol supplementation of allergic female mice inhibits development of CD11c+CD11b+ dendritic cells in utero and allergic inflammation in neonates.

Authors:  Hiam Abdala-Valencia; Sergejs Berdnikovs; Frank W Soveg; Joan M Cook-Mills
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-07-11       Impact factor: 5.464

6.  γ-Tocopherol supplementation of allergic female mice augments development of CD11c+CD11b+ dendritic cells in utero and allergic inflammation in neonates.

Authors:  Hiam Abdala-Valencia; Frank Soveg; Joan M Cook-Mills
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-01-22       Impact factor: 5.464

7.  The tumor suppressor gene DAPK2 is induced by the myeloid transcription factors PU.1 and C/EBPα during granulocytic differentiation but repressed by PML-RARα in APL.

Authors:  Magali Humbert; Elena A Federzoni; Adrian Britschgi; Anna M Schläfli; Peter J M Valk; Thomas Kaufmann; Torsten Haferlach; Gerhard Behre; Hans-Uwe Simon; Bruce E Torbett; Martin F Fey; Mario P Tschan
Journal:  J Leukoc Biol       Date:  2013-09-13       Impact factor: 4.962

8.  PU.1 is a major transcriptional activator of the tumour suppressor gene LIMD1.

Authors:  Daniel E Foxler; Victoria James; Samuel J Shelton; Thomas Q de A Vallim; Peter E Shaw; Tyson V Sharp
Journal:  FEBS Lett       Date:  2011-03-12       Impact factor: 4.124

9.  The Src-family kinase inhibitor PP2 rescues inducible differentiation events in emergent retinoic acid-resistant myeloblastic leukemia cells.

Authors:  Holly A Jensen; Lauren E Styskal; Ryan Tasseff; Rodica P Bunaciu; Johanna Congleton; Jeffrey D Varner; Andrew Yen
Journal:  PLoS One       Date:  2013-03-15       Impact factor: 3.240

10.  Mechanism and function of Vav1 localisation in TCR signalling.

Authors:  Olga Ksionda; Alexander Saveliev; Robert Köchl; Jonathan Rapley; Mustapha Faroudi; Jennifer E Smith-Garvin; Christoph Wülfing; Katrin Rittinger; Tom Carter; Victor L J Tybulewicz
Journal:  J Cell Sci       Date:  2012-09-06       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.